Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy   |   
enzyme (lysozyme)

 
Enzymes
  Enzyme classes:
  EC 1: Oxidoreductases
  EC 2: Transferases
  EC 3: Hydrolases
    EC 3.1
    EC 3.2
    EC 3.3
    EC 3.4
      EC 3.4.1
      EC 3.4.2
      EC 3.4.3
      EC 3.4.4
      EC 3.4.11
      EC 3.4.12
      EC 3.4.13
      EC 3.4.14
      EC 3.4.15
      EC 3.4.16
      EC 3.4.17
      EC 3.4.18
      EC 3.4.19
      EC 3.4.21
      EC 3.4.22
      EC 3.4.23
      EC 3.4.24
      EC 3.4.25
        EC 3.4.25.1
      EC 3.4.99
    EC 3.5
    EC 3.6
    EC 3.7
    EC 3.8
    EC 3.9
    EC 3.10
    EC 3.11
    EC 3.12
    EC 3.13
  EC 4: Lyases
  EC 5: Isomerases
  EC 6: Ligases
  General information:
  Catalytic mechanism
  Enzyme kinetics
  Inhibitors
  Enzymes in industry

EC 3.4.25.1 - proteasome endopeptidase complex



3D structures of EC 3.4.25.1 - proteasome endopeptidase complex in Protein Data Bank

updated: 6 January 2022, 2:15

In total: 401 PDB structures of EC 3.4.25.1 - proteasome endopeptidase complex:
  1. 1g65: Crystal Structure of Epoxomicin:20s Proteasome Reveals a Molecular Basis for Selectivity of Alpha,beta-epoxyketone Proteasome Inhibitors
  2. 1j2p: Alpha-ring from The Proteasome from Archaeoglobus Fulgidus
  3. 1j2q: 20s Proteasome in Complex with Calpain-inhibitor I from Archaeoglobus Fulgidus
  4. 3mka: Crystal Structure of Mycobacterium Tuberculosis Proteasome with Propetide and an T1A Mutation at Beta-subunit
  5. 3mi0: Crystal Structure of Mycobacterium Tuberculosis Proteasome at 2.2 a
  6. 3mfe: Crystal Structure of Mycobacterium Tuberculosis Proteasome Open-gate Mutant with H0 Movement
  7. 3krd: Crystal Structure of Mycobacterium Tuberculosis Proteasome in Complex with Fellutamide B
  8. 3jtl: Crystal Structure of Archaeal 20s Proteasome in Complex with Mutated P26 Activator
  9. 3jse: Crystal Structure of Archaeal 20s Proteasome in Complex with Mutated P26 Activator
  10. 3jrm: Crystal Structure of Archaeal 20s Proteasome in Complex with Mutated P26 Activator
  11. 3ipm: Crystal Structure of Archaeal 20s Proteasome in Complex with The C- Terminus of Pan
  12. 1q5q: The Rhodococcus 20s Proteasome
  13. 1q5r: The Rhodococcus 20s Proteasome with Unprocessed Pro-peptides
  14. 3hye: Crystal Structure of 20s Proteasome in Complex with Hydroxylated Salinosporamide
  15. 3hfa: Crystal Structure of Mycobacterium Tuberculosis Proteasome Open-gate Mutant
  16. 3hf9: Crystal Structure of Mycobacterium Tuberculosis Proteasome Open-gate Mutant Modified by Inhibitor Gl1
  17. 3h6i: Crystal Structure of Mycobacterium Tuberculosis Proteasome Modified by Inhibitor Gl1
  18. 3h6f: Crystal Structure of Mycobacterium Tuberculosis Proteasome Modified by Inhibitor Ht1171
  19. 3h4p: Proteasome 20s Core Particle from Methanocaldococcus Jannaschii
  20. 3gpw: Crystal Structure of The Yeast 20s Proteasome in Complex with Salinosporamide Derivatives: Irreversible Inhibitor Ligand
  21. 3gpt: Crystal Structure of The Yeast 20s Proteasome in Complex with Salinosporamide Derivatives: Slow Substrate Ligand
  22. 3gpj: Crystal Structure of The Yeast 20s Proteasome in Complex with Syringolin B
  23. 3e47: Crystal Structure of The Yeast 20s Proteasome in Complex with Homobelactosin C
  24. 3dy4: Crystal Structure of Yeast 20s Proteasome in Complex with Spirolactacystin
  25. 3dy3: Crystal Structure of Yeast 20s Proteasome in Complex with The Epimer Form of Spirolactacystin
  26. 3d29: Proteasome Inhibition by Fellutamide B
  27. 3c92: Thermoplasma Acidophilum 20s Proteasome with a Closed Gate
  28. 3c91: Thermoplasma Acidophilum 20s Proteasome with an Open Gate
  29. 3bdm: Yeast 20s Proteasome:glidobactin A-complex
  30. 2zcy: Yeast 20s Proteasome:syringolin A-complex
  31. 2z5c: Crystal Structure of a Novel Chaperone Complex for Yeast 20s Proteasome Assembly
  32. 1ya7: Implications for Interactions of Proteasome with Pan and Pa700 from The 1.9 a Structure of a Proteasome-11s Activator Complex
  33. 1yar: Structure of Archeabacterial 20s Proteasome Mutant D9S- Pa26 Complex
  34. 1yau: Structure of Archeabacterial 20s Proteasome- Pa26 Complex
  35. 1z7q: Crystal Structure of The 20s Proteasome from Yeast in Complex with The Proteasome Activator Pa26 from Trypanosome Brucei at 3.2 Angstroms Resolution
  36. 6z46: Structure of The S. Acidocaldarius 20s Proteasome (saci0613/saci0662)
  37. 6xmj: Human 20s Proteasome Bound to an Engineered 11s (pa26) Activator
  38. 6bgo: Singly Pafe-capped 20s Cp in Mycobacterium Tuberculosis
  39. 6bgl: Doubly Pafe-capped 20s Core Particle in Mycobacterium Tuberculosis
  40. 6bdf: 2.8 a Resolution Reconstruction of The Thermoplasma Acidophilum 20s Proteasome Using Cryo-electron Microscopy
  41. 6avo: Cryo-em Structure of Human Immunoproteasome with a Novel Noncompetitive Inhibitor That Selectively Inhibits Activated Lymphocytes
  42. 2f16: Crystal Structure of The Yeast 20s Proteasome in Complex with Bortezomib
  43. 2fak: Crystal Structure of Salinosporamide a in Complex with The Yeast 20s Proteasome
  44. 2gpl: Tmc-95 Based Biphenyl-ether Macrocycles: Specific Proteasome Inhibitors
  45. 2h6j: Crystal Structure of The Beta F145A Rhodococcus Proteasome (casp Target)
  46. 2jay: Proteasome Beta Subunit Prcb from Mycobacterium Tuberculosis
  47. 6wjn: Sd-like State of Human 26s Proteasome with Non-cleavable M1-linked Hexaubiquitin and E3 Ubiquitin Ligase E6AP/UBE3A
  48. 6wnk: Macrocyclic Peptides Tdi5575 That Selectively Inhibit The Mycobacterium Tuberculosis Proteasome
  49. 6utj: Allosteric Couple between Alpha Rings of The 20s Proteasome. 20s Proteasome Singly Capped by PA26/E102A, C-terminus Replaced by Pan C- Terminus
  50. 6uti: Allosteric Coupling between Alpha-rings of 20s Proteasome, 20s Proteasome with Singly Capped Pan Complex
  51. 6uth: Allosteric Coupling between Alpha-rings of 20s Proteasome, 20s Proteasome Singly Capped with a PA26/E102A_PANC, Together with Lfp Incubation
  52. 6utg: Allosteric Coupling between Alpha-rings of The 20s Proteasome, 20s Singly Capped with a PA26/V230F
  53. 6utf: Allosteric Coupling between Alpha-rings of The 20s Proteasome, Archaea 20s Proteasome Singly Capped with a Pan Complex
  54. 6td5: Leishmania Tarentolae Proteasome 20s Subunit Complexed with Lxe408 and Bortezomib
  55. 6tcz: Leishmania Tarentolae Proteasome 20s Subunit Complexed with Lxe408
  56. 2ku1: Dynamic Regulation of Archaeal Proteasome Gate Opening as Studied by Trosy-nmr
  57. 2ku2: Dynamic Regulation of Archaeal Proteasome Gate Opening as Studied by Trosy-nmr
  58. 3nzj: Crystal Structure of Yeast 20s Proteasome in Complex with Ligand 2a
  59. 3nzw: Crystal Structure of The Yeast 20s Proteasome in Complex with 2b
  60. 3nzx: Crystal Structure of The Yeast 20s Proteasome in Complex with Ligand 2c
  61. 6tu3: Rat 20s Proteasome
  62. 3mg4: Structure of Yeast 20s Proteasome with Compound 1
  63. 3mg0: Structure of Yeast 20s Proteasome with Bortezomib
  64. 3mg6: Structure of Yeast 20s Open-gate Proteasome with Compound 6
  65. 3mg7: Structure of Yeast 20s Open-gate Proteasome with Compound 8
  66. 3mg8: Structure of Yeast 20s Open-gate Proteasome with Compound 16
  67. 6kwy: Human Pa200-20s Complex
  68. 3oeu: Structure of Yeast 20s Open-gate Proteasome with Compound 24
  69. 3oev: Structure of Yeast 20s Open-gate Proteasome with Compound 25
  70. 3okj: Alpha-keto-aldehyde Binding Mechanism Reveals a Novel Lead Structure Motif for Proteasome Inhibition
  71. 3tdd: Crystal Structure of Yeast Cp in Complex with Belactosin C
  72. 6rgq: Human 20s Proteasome
  73. 6rey: Human 20s-pa200 Proteasome Complex
  74. 6r70: Endogeneous Native Human 20s Proteasome
  75. 3shj: Proteasome in Complex with Hydroxyurea Derivative Hu10
  76. 3un4: Yeast 20s Proteasome in Complex with Pr-957 (morpholine)
  77. 3un8: Yeast 20s Proteasome in Complex with Pr-957 (epoxide)
  78. 3unb: Mouse Constitutive 20s Proteasome in Complex with Pr-957
  79. 3une: Mouse Constitutive 20s Proteasome
  80. 3unh: Mouse 20s Immunoproteasome
  81. 6ode: Crystal Structure of Mycobacterium Tuberculosis Proteasome in Complex with Phenylimidazole-based Inhibitor B6
  82. 6ocz: Crystal Structure of Mycobacterium Tuberculosis Proteasome in Complex with Phenylimidazole-based Inhibitor A86
  83. 6ocw: Crystal Structure of Mycobacterium Tuberculosis Proteasome in Complex with Phenylimidazole-based Inhibitor A85
  84. 3sdi: Structure of Yeast 20s Open-gate Proteasome with Compound 20
  85. 3sdk: Structure of Yeast 20s Open-gate Proteasome with Compound 34
  86. 6mux: The Structure of The Plasmodium Falciparum 20s Proteasome in Complex with One Pa28 Activator
  87. 6muw: The Structure of The Plasmodium Falciparum 20s Proteasome.
  88. 6muv: The Structure of The Plasmodium Falciparum 20s Proteasome in Complex with Two Pa28 Activators
  89. 4g4s: Structure of Proteasome-pba1-pba2 Complex
  90. 4gk7: Yeast 20s Proteasome in Complex with The Syringolin-glidobactin Chimera
  91. 4fzc: 20s Yeast Proteasome in Complex with Cepafungin I
  92. 4fzg: 20s Yeast Proteasome in Complex with Glidobactin
  93. 6hwf: Yeast 20s Proteasome BETA2-G45A Mutant in Complex with Onx 0914
  94. 6hwe: Yeast 20s Proteasome BETA2-G45A Mutant in Complex with Carfilzomib
  95. 6hwd: Yeast 20s Proteasome BETA2-G45A Mutant in Complex with Bortezomib
  96. 6hwc: Yeast 20s Proteasome BETA2-G45A Mutant
  97. 6hwb: Yeast 20s Proteasome in Complex with 44b
  98. 6hwa: Yeast 20s Proteasome in Complex with 43
  99. 6hw9: Yeast 20s Proteasome in Complex with 41b
  100. 6hw8: Yeast 20s Proteasome in Complex with 39
  101. 6hw7: Yeast 20s Proteasome in Complex with 29
  102. 6hw6: Yeast 20s Proteasome in Complex with 20
  103. 6hw5: Yeast 20s Proteasome in Complex with 18
  104. 6hw4: Yeast 20s Proteasome in Complex with 16
  105. 6hw3: Yeast 20s Proteasome in Complex with 13
  106. 6hw0: Yeast 20s Proteasome in Complex with 7
  107. 6hvy: Yeast 20s Proteasome in Complex with 5 (7- and 6-membered Ring)
  108. 6hvx: Yeast 20s Proteasome in Complex with 4
  109. 6hvw: Yeast 20s Proteasome with Human BETA2I (1-53) in Complex with 43
  110. 6hvv: Yeast 20s Proteasome with Human BETA2I (1-53) in Complex with 39
  111. 6hvu: Yeast 20s Proteasome with Human BETA2I (1-53) in Complex with 29
  112. 6hvt: Yeast 20s Proteasome with Human BETA2I (1-53) in Complex with 20
  113. 6hvs: Yeast 20s Proteasome with Human BETA2I (1-53) in Complex with 18
  114. 6hvr: Yeast 20s Proteasome with Human BETA2I (1-53) in Complex with 16
  115. 6hva: Yeast 20s Proteasome with Human BETA2I (1-53) in Complex with 13
  116. 6hv7: Yeast 20s Proteasome with Human BETA2I (1-53) in Complex with 7
  117. 6hv5: Yeast 20s Proteasome with Human BETA2I (1-53) in Complex with 4
  118. 6hv4: Yeast 20s Proteasome with Human BETA2I (1-53) in Complex with Onx 0914
  119. 6hv3: Yeast 20s Proteasome with Human BETA2I (1-53)
  120. 6huv: Yeast 20s Proteasome with Human BETA2C (S171G) in Complex with 39
  121. 6huu: Yeast 20s Proteasome with Human BETA2C (S171G) in Complex with 29
  122. 6huq: Yeast 20s Proteasome with Human BETA2C (S171G) in Complex with 20
  123. 6huc: Yeast 20s Proteasome with Human BETA2C (S171G) in Complex with 18
  124. 6hub: Yeast 20s Proteasome with Human BETA2C (S171G) in Complex with 16
  125. 6htr: Yeast 20s Proteasome with Human BETA2C (S171G) in Complex with 13
  126. 6htp: Yeast 20s Proteasome with Human BETA2C (S171G) in Complex with 7
  127. 6htd: Yeast 20s Proteasome with Human BETA2C (S171G) in Complex with 4
  128. 6htc: Yeast 20s Proteasome with Human BETA2C (S171G) in Complex with Onx 0914
  129. 6htb: Yeast 20s Proteasome with Human BETA2C (S171G)
  130. 4inr: Yeast 20s Proteasome in Complex with The Vinyl Sulfone Lu102
  131. 4int: Yeast 20s Proteasome in Complex with The Vinyl Sulfone Lu122
  132. 4inu: Yeast 20s Proteasome in Complex with The Vinyl Sulfone Lu112
  133. 6hed: Pan-proteasome in State 5
  134. 6hec: Pan-proteasome in State 4
  135. 6hea: Pan-proteasome in State 3
  136. 6he9: Pan-proteasome in State 2
  137. 6he8: Pan-proteasome in State 1
  138. 6he7: 20s Proteasome from Archaeoglobus Fulgidus
  139. 6he5: 20s Core Particle of Pan-proteasomes
  140. 6h39: Yeast 20s Proteasome in Complex with The Peptidic Non-covalent Binding Inhibitor Rts-v5
  141. 6gop: Yeast 20s Proteasome in Complex with Homosalinosporamide a
  142. 4j70: Yeast 20s Proteasome in Complex with The Belactosin Derivative 3e
  143. 4eu2: Crystal Structure of 20s Proteasome with Novel Inhibitor K-7174
  144. 4jsq: Yeast 20s Proteasome in Complex with The Dimerized Linear Mimetic of Tmc-95a - Ycp:4e
  145. 4jsu: Yeast 20s Proteasome in Complex with The Dimerized Linear Mimetic of Tmc-95a - Ycp:3a
  146. 4jt0: Yeast 20s Proteasome in Complex with The Dimerized Linear Mimetic of Tmc-95a - Ycp:4a
  147. 6g8n: Yeast 20s Proteasome in Complex with Cystargolide B Derivative 2
  148. 6g8m: Yeast 20s Proteasome in Complex with Cystargolide B Derivative 1
  149. 6g7f: Yeast 20s Proteasome in Complex with Cystargolide B
  150. 6epf: Ground State 26s Proteasome (gs1)
  151. 6epe: Substrate Processing State 26s Proteasome (sps2)
  152. 6epd: Substrate Processing State 26s Proteasome (sps1)
  153. 6epc: Ground State 26s Proteasome (gs2)
  154. 6ef3: Yeast 26s Proteasome Bound to Ubiquitinated Substrate (4d Motor State)
  155. 6ef2: Yeast 26s Proteasome Bound to Ubiquitinated Substrate (5t Motor State)
  156. 6ef1: Yeast 26s Proteasome Bound to Ubiquitinated Substrate (5d Motor State)
  157. 6ef0: Yeast 26s Proteasome Bound to Ubiquitinated Substrate (1d* Motor State)
  158. 6e5b: Human Immunoproteasome 20s Particle in Complex with Compound 1
  159. 3wxr: Yeast 20s Proteasome with a Mutation of Alpha7 Subunit
  160. 4cr2: Deep Classification of a Large Cryo-em Dataset Defines The Conformational Landscape of The 26s Proteasome
  161. 4cr3: Deep Classification of a Large Cryo-em Dataset Defines The Conformational Landscape of The 26s Proteasome
  162. 4cr4: Deep Classification of a Large Cryo-em Dataset Defines The Conformational Landscape of The 26s Proteasome
  163. 4hnp: Crystal Structure of Yeast 20s Proteasome in Complex with Vinylketone Carmaphycin Analogue Vnk1
  164. 4hrc: Crystal Structure of Yeast 20s Proteasome in Complex with Epoxyketone Carmaphycin Analogue 3
  165. 4hrd: Crystal Structure of Yeast 20s Proteasome in Complex with The Natural Product Carmaphycin a
  166. 4lqi: Yeast 20s Proteasome in Complex with Vibralactone
  167. 4ltc: Crystal Structure of Yeast 20s Proteasome in Complex with Enone Carmaphycin Analogue 6
  168. 4nnn: Ycp in Complex with Mg132
  169. 4no1: Ycp in Complex with Z-leu-leu-leu-b(oh)2
  170. 4no6: Ycp in Complex with Z-leu-leu-leu-vinylsulfone
  171. 4no8: Ycp in Complex with Z-leu-leu-leu-ketoamide
  172. 4no9: Ycp in Complex with Z-leu-leu-leu-epoxyketone
  173. 4q1s: Yeast 20s Proteasome in Complex with Kendomycin
  174. 4qby: Ycp in Complex with Boc-ala-ala-ala-cho
  175. 4qlq: Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 8
  176. 4qls: Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 11
  177. 4qlt: Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 2 (pr924)
  178. 4qlu: Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 9
  179. 4qlv: Ycp in Complex with Tripeptidic Epoxyketone Inhibitor 17
  180. 5vy4: Thermoplasma Acidophilum 20s Proteasome Using 200kev with Image Shift
  181. 4r02: Ycp in Complex with Bsc4999 (alpha-keto Phenylamide)
  182. 4r17: Ligand-induced Aziridine-formation at Subunit Beta5 of The Yeast 20s Proteasome
  183. 4r18: Ligand-induced Lys33-thr1 Crosslinking at Subunit Beta5 of The Yeast 20s Proteasome
  184. 5vy3: Thermoplasma Acidophilum 20s Proteasome Using 200kev with Stage Position
  185. 5vft: Nucleotide-driven Triple-state Remodeling of The Aaa-atpase Channel in The Activated Human 26s Proteasome
  186. 5vfr: Nucleotide-driven Triple-state Remodeling of The Aaa-atpase Channel in The Activated Human 26s Proteasome
  187. 5vfo: Nucleotide-driven Triple-state Remodeling of The Aaa-atpase Channel in The Activated Human 26s Proteasome
  188. 5ts0: Structure of Mycobacterium Tuberculosis Proteasome in Complex with N, C-capped Dipeptide Pks2208
  189. 5try: Structure of Mycobacterium Tuberculosis Proteasome in Complex with N, C-capped Dipeptide Pks2206
  190. 5trs: Structure of Mycobacterium Tuberculosis Proteasome in Complex with N, C-capped Dipeptide Pks2144
  191. 5trr: Structure of Mycobacterium Tuberculosis Proteasome in Complex with N, C-capped Dipeptide Pks2169
  192. 5trg: Structure of Mycobacterium Tuberculosis Proteasome in Complex with N, C-capped Dipeptide Dplg-2
  193. 5tho: Crystal Structure of Mycobacterium Tuberculosis Proteasome in Complex with N,c-capped Dipeptide Inhibitor Pks2205
  194. 5t0j: Structural Basis for Dynamic Regulation of The Human 26s Proteasome
  195. 5t0i: Structural Basis for Dynamic Regulation of The Human 26s Proteasome
  196. 5t0h: Structural Basis for Dynamic Regulation of The Human 26s Proteasome
  197. 5t0g: Structural Basis for Dynamic Regulation of The Human 26s Proteasome
  198. 5nif: Yeast 20s Proteasome in Complex with Blm-pep Activator
  199. 5mpa: 26s Proteasome in Presence of Atp (s2)
  200. 5mp9: 26s Proteasome in Presence of Atp (s1)
  201. 5m32: Human 26s Proteasome in Complex with Oprozomib
  202. 5m2b: Yeast 20s Proteasome with Human BETA5I (1-138) and Human Beta6 (97- 111; 118-133) in Complex with Thiazole Based Inhibitor Ro19
  203. 5lzp: Binding of The C-terminal Gqyl Motif of The Bacterial Proteasome Activator Bpa to The 20s Proteasome
  204. 5ltt: Yeast 20s Proteasome with Human BETA5I (1-138; R57T)IN Complex with Pr-924
  205. 5ln3: The Human 26s Proteasome at 6.8 Ang.
  206. 5lf7: Human 20s Proteasome Complex with Ixazomib at 2.0 Angstrom
  207. 5lf6: Human 20s Proteasome Complex with Z-lly-ketoaldehyde at 2.1 Angstrom
  208. 5lf4: Human 20s Proteasome Complex with Delanzomib at 2.0 Angstrom
  209. 5lf3: Human 20s Proteasome Complex with Bortezomib at 2.1 Angstrom
  210. 5lf1: Human 20s Proteasome Complex with Dihydroeponemycin at 2.0 Angstrom
  211. 5lf0: Human 20s Proteasome Complex with Epoxomicin at 2.4 Angstrom
  212. 5lez: Human 20s Proteasome Complex with Oprozomib in Mg-acetate at 2.2 Angstrom
  213. 5ley: Human 20s Proteasome Complex with Oprozomib at 1.9 Angstrom
  214. 5lex: Native Human 20s Proteasome in Mg-acetate at 2.2 Angstrom
  215. 5le5: Native Human 20s Proteasome at 1.8 Angstrom
  216. 5laj: Ligand-induced Lys33-thr1 Crosslinking at The Yeast Proteasomal Subunit Beta5 by Sulfonate Esters
  217. 5lai: Ligand-induced Aziridine-formation at The Yeast Proteasomal Subunit Beta5 by Sulfonate Esters
  218. 5l6c: Yeast 20s Proteasome with Mouse BETA5I (1-138) and Mouse Beta6 (97- 111; 118-133) in Complex with Epoxyketone Inhibitor 18
  219. 5l6b: Yeast 20s Proteasome with Mouse BETA5I (1-138) and Mouse Beta6 (97- 111; 118-133) in Complex with Onx 0914
  220. 5l6a: Yeast 20s Proteasome with Mouse BETA5I (1-138) and Mouse Beta6 (97- 111; 118-133) in Complex with Epoxyketone Inhibitor 17
  221. 5l69: Yeast 20s Proteasome with Mouse BETA5I (1-138) and Mouse Beta6 (97- 111; 118-133) in Complex with Epoxyketone Inhibitor 16
  222. 5l68: Yeast 20s Proteasome with Mouse BETA5I (1-138) and Mouse Beta6 (97- 111; 118-133) in Complex with Epoxyketone Inhibitor 14
  223. 5l67: Yeast 20s Proteasome with Mouse BETA5I (1-138) and Mouse Beta6 (97- 111; 118-133) in Complex with Pr-924
  224. 5l66: Yeast 20s Proteasome with Mouse BETA5I (1-138) and Mouse Beta6 (97- 111; 118-133) in Complex with Bortezomib
  225. 5l65: Yeast 20s Proteasome with Mouse BETA5I (1-138) and Mouse Beta6 (97- 111; 118-133) in Complex with Carfilzomib
  226. 5l64: Yeast 20s Proteasome with Human BETA5C (1-138) and Human Beta6 (97- 111; 118-133) in Complex with Epoxyketone Inhibitor 18
  227. 5l63: Yeast 20s Proteasome with Human BETA5C (1-138) and Human Beta6 (97- 111; 118-133) in Complex with Epoxyketone Inhibitor 17
  228. 5l62: Yeast 20s Proteasome with Human BETA5C (1-138) and Human Beta6 (97- 111; 118-133) in Complex with Epoxyketone Inhibitor 16
  229. 5l61: Yeast 20s Proteasome with Human BETA5C (1-138) and Human Beta6 (99- 132) in Complex with Epoxyketone Inhibitor 14
  230. 5l60: Yeast 20s Proteasome with Human BETA5C (1-138) and Human Beta6 (97- 111; 118-133) in Complex with Pr-924
  231. 5l5z: Yeast 20s Proteasome with Human BETA5C (1-138) and Human Beta6 (97- 111; 118-133) in Complex with Bortezomib
  232. 5l5y: Yeast 20s Proteasome with Human BETA5C (1-138) and Human Beta6 (97- 111; 118-133) in Complex with Carfilzomib
  233. 5l5x: Yeast 20s Proteasome with Human BETA5C (1-138) and Human Beta6 (97- 111; 118-133) in Complex with Onx 0914
  234. 5l5w: Yeast 20s Proteasome with Human BETA5C (1-138) and Human Beta6 (97- 111; 118-133)
  235. 5l5v: 'yeast 20s Proteasome with Human BETA5I (1-138; V31M) and Human Beta6 (97-111; 118-133) in Complex with Epoxyketone Inhibitor 18
  236. 5l5u: Yeast 20s Proteasome with Human BETA5I (1-138; V31M) and Human Beta6 (97-111; 118-133) in Complex with Epoxyketone Inhibitor 17
  237. 5l5t: Yeast 20s Proteasome with Human BETA5I (1-138; V31M) and Human Beta6 (97-111; 118-133) in Complex with Epoxyketone Inhibitor 16
  238. 5l5s: Yeast 20s Proteasome with Human BETA5I (1-138; V31M) and Human Beta6 (97-111; 118-133) in Complex with Pr-924
  239. 5l5r: Yeast 20s Proteasome with Human BETA5I (1-138;V31M) and Human Beta6 (97-111; 118-133)
  240. 5l5q: Yeast 20s Proteasome with Human BETA5I (1-138) and Human Beta6 (97- 111; 118-133) in Complex with Epoxyketone 18
  241. 5l5p: Yeast 20s Proteasome with Human BETA5I (1-138) and Human Beta6 (97- 111; 118-133) in Complex with Epoxyketone Inhibitor 17
  242. 5l5o: Yeast 20s Proteasome with Human BETA5I (1-138) and Human Beta6 (97- 111; 118-133) in Complex with Epoxyketone Inhibitor 16
  243. 5l5j: Yeast 20s Proteasome with Human BETA5I (1-138) and Human Beta6 (97- 111; 118-133) in Complex with Epoxyketone Inhibitor 14
  244. 5l5i: Yeast 20s Proteasome with Human BETA5I (1-138) and Human Beta6 (97- 111; 118-133) in Complex with Epoxyketone Inhibitor 9
  245. 5l5h: Yeast 20s Proteasome with Human BETA5I (1-138) and Human Beta6 (97- 111; 118-133) in Complex with Pr-924
  246. 5l5f: Yeast 20s Proteasome with Human BETA5I (1-138) and Human Beta6 (97- 111; 118-133) in Complex with Bortezomib
  247. 5l5e: Yeast 20s Proteasome with Human BETA5I (1-138) and Human Beta6 (97- 111; 118-133) in Complex with Carfilzomib
  248. 5l5d: Yeast 20s Proteasome with Human BETA5I (1-138) and Human Beta6 (97- 111; 118-133) in Complex with Onx 0914
  249. 5l5b: Yeast 20s Proteasome with Human BETA5I (1-138) and Human Beta6 (97- 111; 118-133)
  250. 5l5a: Yeast 20s Proteasome with Human BETA5I (1-138; R57T)
  251. 5l55: Yeast 20s Proteasome in Complex with Epoxyketone Inhibitor 18
  252. 5l54: Yeast 20s Proteasome in Complex with Epoxyketone Inhibitor 16
  253. 5l52: Yeast 20s Proteasome in Complex with Epoxyketone Inhibitor 14
  254. 5jhs: Yeast 20s Proteasome in Complex with The Peptidic Epoxyketone Inhibitor 15
  255. 5jhr: Yeast 20s Proteasome in Complex with The Peptidic Epoxyketone Inhibitor 27
  256. 5gjq: Structure of The Human 26s Proteasome Bound to Usp14-ubal
  257. 5fmg: Structure and Function Based Design of Plasmodium-selective Proteasome Inhibitors
  258. 5fhs: Yeast 20s Proteasome BETA5-K33A Mutant (propeptide Expressed in Trans) in Complex with Carfilzomib
  259. 5fgi: Yeast 20s Proteasome BETA1-T1A BETA2-T1A Double Mutant in Complex with Carfilzomib
  260. 5fgh: Yeast 20s Proteasome BETA5-K33A Mutant (propeptide Expressed in Trans) in Complex with Mg132
  261. 5fgg: Yeast 20s Proteasome BETA5-L(-49S)_D17N Double Mutant in Complex with Carfilzomib
  262. 5fgf: Yeast 20s Proteasome BETA5-H(-2)A-T1A-K81R Triple Mutant in Complex with Carfilzomib
  263. 5fge: Yeast 20s Proteasome BETA5-H(-2)T-T1A Double Mutant in Complex with Carfilzomib
  264. 5fgd: Yeast 20s Proteasome BETA5-H(-2)L-T1A Double Mutant in Complex with Carfilzomib
  265. 5fga: Yeast 20s Proteasome BETA5-K33A Mutant (propeptide Expressed in Trans)
  266. 5fg9: Yeast 20s Proteasome Beta2-t(-2)v Mutant
  267. 5fg7: Yeast 20s Proteasome BETA2-T1A Mutant
  268. 5dsv: Crystal Structure of Human Proteasome Alpha7 Tetradecamer
  269. 5dkj: Yeast 20s Proteasome in Complex with Octreotide-pi
  270. 5dki: Yeast 20s Proteasome in Complex with Alkyne-pi
  271. 5d0z: Yeast 20s Proteasome BETA5-T1S Mutant in Complex with Carfilzomib
  272. 5d0x: Yeast 20s Proteasome BETA5-T1S Mutant in Complex with Bortezomib
  273. 5d0w: Yeast 20s Proteasome BETA5-T1S Mutant
  274. 5d0v: Yeast 20s Proteasome BETA5-T1C Mutant in Complex with Carfilzomib
  275. 5d0t: Yeast 20s Proteasome BETA5-D166N Mutant in Complex with Mg132
  276. 5d0s: Yeast 20s Proteasome BETA5-D166N Mutant in Complex with Carfilzomib
  277. 5cza: Yeast 20s Proteasome BETA5-D166N Mutant
  278. 5cz9: Yeast 20s Proteasome BETA5-D17N Mutant in Complex with Carfilzomib; Propeptide Expressed in Trans
  279. 5cz8: Yeast 20s Proteasome BETA5-L(-49)S-K33A Mutant in Complex with Carfilzomib
  280. 5cz7: Yeast 20s Proteasome BETA5-T1A BETA5-K81R Double Mutant in Complex with Bortezomib, Propeptide Expressed in Cis
  281. 5cz6: Yeast 20s Proteasome BETA5-T1A Mutant in Complex with Syringolin A, Propeptide Expressed in Trans
  282. 5cz5: Yeast 20s Proteasome BETA1-T1A Mutant in Complex with Carfilzomib
  283. 5cz4: Yeast 20s Proteasome at 2.3 a Resolution
  284. 5cgi: Yeast 20s Proteasome BETA5-G48C Mutant in Complex with Onx 0914
  285. 5cgh: Yeast 20s Proteasome BETA5-G48C Mutant in Complex with Alpha- Chloroacetamide 5
  286. 5cgg: Yeast 20s Proteasome BETA5-G48C Mutant in Complex with Alpha- Chloroacetamide 1
  287. 5cgf: Yeast 20s Proteasome BETA5-G48C Mutant
  288. 5bxn: Yeast 20s Proteasome BETA2-G170A Mutant in Complex with Bortezomib
  289. 5bxl: Yeast 20s Proteasome BETA2-G170A Mutant
  290. 4rur: Yeast 20s Proteasome in Complex with The Alkaloid Indolo-phakellin (4)
  291. 4qux: Ycp BETA5-A49T-MUTANT
  292. 5bou: Yeast 20s Proteasome in Complex with a Beta1 / Beta2 Specific Non- Peptidic Sulfonamide Ligand
  293. 4quy: Ycp BETA5-A49S-MUTANT
  294. 4qv0: Ycp BETA5-A49T-A50V-DOUBLE Mutant
  295. 4qv1: Ycp BETA5-M45A Mutant
  296. 4qv3: Ycp BETA5-M45V Mutant
  297. 4qv4: Ycp BETA5-M45T Mutant
  298. 4qv5: Ycp BETA5-M45I Mutant
  299. 4qv6: Ycp BETA5-A49V Mutant
  300. 4qv7: Ycp BETA5-A50V Mutant
  301. 4qv8: Ycp BETA5-C52F Mutant
  302. 4qv9: Ycp BETA5-C63F Mutant
  303. 4qvl: Ycp in Complex with Bortezomib
  304. 4qvm: Ycp BETA5-M45A Mutant in Complex with Bortezomib
  305. 4qvn: Ycp BETA5-M45V Mutant in Complex with Bortezomib
  306. 4qvp: Ycp BETA5-M45T Mutant in Complex with Bortezomib
  307. 4qvq: Ycp BETA5-M45I Mutant in Complex with Bortezomib
  308. 4qvv: Ycp BETA5-A49V Mutant in Complex with Bortezomib
  309. 4qvw: Ycp BETA5-A49S-MUTANT in Complex with Bortezomib
  310. 4qvy: Ycp BETA5-A49T-MUTANT in Complex with Bortezomib
  311. 4qw0: Ycp BETA5-A49T-A50V-DOUBLE Mutant in Complex with Bortezomib
  312. 4qw1: Ycp BETA5-A50V Mutant in Complex with Bortezomib
  313. 4qw3: Ycp BETA5-C63F Mutant in Complex with Bortezomib
  314. 4qw4: Ycp in Complex with Carfilzomib
  315. 4qw5: Ycp BETA5-M45A Mutant in Complex with Carfilzomib
  316. 4qw6: Ycp BETA5-M45V Mutant in Complex with Carfilzomib
  317. 4qw7: Ycp BETA5-M45T Mutant in Complex with Carfilzomib
  318. 4qwr: Ycp BETA5-C52F Mutant in Complex with Carfilzomib
  319. 4qws: Ycp BETA5-C63F Mutant in Complex with Carfilzomib
  320. 4qwu: Ycp BETA5-C52F Mutant in Complex with Bortezomib
  321. 4qwx: Ycp in Complex with The Epoxyketone Inhibitor Onx 0914
  322. 4qxj: Ycp BETA5-M45A Mutant in Complex with The Epoxyketone Inhibitor Onx 0914
  323. 4qz0: Ycp BETA5-M45V Mutant in Complex with The Epoxyketone Inhibitor Onx 0914
  324. 4qz1: Ycp BETA5-M45T Mutant in Complex with The Epoxyketone Inhibitor Onx 0914
  325. 4qz2: Ycp BETA5-M45I Mutant in Complex with The Epoxyketone Inhibitor Onx 0914
  326. 4qz3: Ycp BETA5-A49V Mutant in Complex with The Epoxyketone Inhibitor Onx 0914
  327. 4qz4: Ycp BETA5-A49S Mutant in Complex with The Epoxyketone Inhibitor Onx 0914
  328. 4qz5: Ycp BETA5-A49T-MUTANT in Complex with Onx 0914
  329. 4qz6: Ycp BETA5-A49T-A50V Double Mutant in Complex with The Epoxyketone Inhibitor Onx 0914
  330. 4qz7: Ycp BETA5-A50V Mutant in Complex with The Epoxyketone Inhibitor Onx 0914
  331. 4qzw: Ycp BETA5-C52F Mutant in Complex with The Epoxyketone Inhibitor Onx 0914
  332. 4qzx: Ycp BETA5-C63F Mutant in Complex with The Epoxyketone Inhibitor Onx 0914
  333. 4qzz: Ycp in Complex with Omuralide
  334. 4r00: Ycp BETA5-C52F Mutant in Complex with Omuralide
  335. 4r3o: Human Constitutive 20s Proteasome
  336. 4r67: Human Constitutive 20s Proteasome in Complex with Carfilzomib
  337. 5a5b: Structure of The 26s Proteasome-ubp6 Complex
  338. 5a0q: Cryo-em Reveals The Conformation of a Substrate Analogue in The Human 20s Proteasome Core
  339. 3j9i: Thermoplasma Acidophilum 20s Proteasome
  340. 5ahj: Yeast 20s Proteasome in Complex with Macyranone a
  341. 4ya9: Yeast 20s Proteasome BETA2-H114D Mutant in Complex with Ac-lad-ep
  342. 4ya7: Yeast 20s Proteasome BETA2-H114D Mutant in Complex with Ac-lae-ep
  343. 4ya5: Yeast 20s Proteasome BETA2-H114D Mutant in Complex with Ac-pae-ep
  344. 4ya4: Yeast 20s Proteasome BETA2-H114D Mutant
  345. 4ya3: Yeast 20s Proteasome BETA2-H116N Mutant in Complex with Ac-pae-ep
  346. 4ya2: Yeast 20s Proteasome BETA2-H116N Mutant in Complex with Ac-lae-ep
  347. 4ya1: Yeast 20s Proteasome BETA2-H116N Mutant
  348. 4ya0: Yeast 20s Proteasome BETA2-H116E Mutant in Complex with Ac-pae-ep
  349. 4y9z: Yeast 20s Proteasome BETA2-H116E Mutant in Complex with Ac-lae-ep
  350. 4y9y: Yeast 20s Proteasome BETA2-H116E Mutant
  351. 4y8u: Yeast 20s Proteasome BETA2-H116D Mutant in Complex with Ac-pad-ep
  352. 4y8t: Yeast 20s Proteasome BETA2-H116D Mutant in Complex with Ac-pae-ep
  353. 4y8s: Yeast 20s Proteasome BETA2-H116D Mutant in Complex with Ac-lae-ep
  354. 4y8r: Yeast 20s Proteasome BETA2-H116D Mutant
  355. 4y8q: Yeast 20s Proteasome Beta7-delta7_cter Mutant in Complex with Ac-pay- Ep
  356. 4y8p: Yeast 20s Proteasome Beta7-delta7_cter Mutant in Complex with Ac-pal- Ep
  357. 4y8o: Yeast 20s Proteasome Beta7-delta7_cter Mutant in Complex with Ac-paf- Ep
  358. 4y8n: Yeast 20s Proteasome Beta7-delta7_cter Mutant in Complex with Ac-pae- Ep
  359. 4y8m: Yeast 20s Proteasome Beta7-delta7_cter Mutant
  360. 4y8l: Yeast 20s Proteasome in Complex with Ac-apll-ep
  361. 4y8k: Yeast 20s Proteasome in Complex with H-apll-ep
  362. 4y8j: Yeast 20s Proteasome in Complex with Ac-lll-ep
  363. 4z1l: Yeast 20s Proteasome in Complex with Belactosin C Derivative 3
  364. 4y8i: Yeast 20s Proteasome in Complex with Ac-pll-ep
  365. 4y8h: Yeast 20s Proteasome in Complex with N3-apal-ep
  366. 4x6z: Yeast 20s Proteasome in Complex with Pr-vi Modulator
  367. 4y69: Yeast 20s Proteasome in Complex with Ac-pad-ep
  368. 4y6a: Yeast 20s Proteasome BETA2-H114D Mutant in Complex with Ac-pad-ep
  369. 4y6v: Yeast 20s Proteasome in Complex with Ac-pae-ep
  370. 4y6z: Yeast 20s Proteasome in Complex with Ac-pal-ep
  371. 4y70: Yeast 20s Proteasome in Complex with Ac-lav-ep
  372. 4y74: Yeast 20s Proteasome in Complex with Ac-lal-ep
  373. 4y75: Yeast 20s Proteasome in Complex with Ac-paf-ep
  374. 4y77: Yeast 20s Proteasome in Complex with Ac-laf-ep
  375. 4y78: Yeast 20s Proteasome in Complex with Ac-lad-ep
  376. 4y7w: Yeast 20s Proteasome in Complex with Ac-lae-ep
  377. 4y7x: Yeast 20s Proteasome in Complex with Ac-paa-ep
  378. 4y7y: Yeast 20s Proteasome in Complex with Ac-laa-ep
  379. 4y80: Yeast 20s Proteasome in Complex with Ac-lai-ep
  380. 4y81: Yeast 20s Proteasome in Complex with Ac-pay-ep
  381. 4y82: Yeast 20s Proteasome in Complex with Ac-lay-ep
  382. 4y84: Yeast 20s Proteasome in Complex with N3-A(4,4-F2P)NLL-EP
  383. 4y8g: Yeast 20s Proteasome in Complex with N3-apnll-ep
  384. 7dr6: PA28ALPHA-BETA in Complex with Immunoproteasome
  385. 7dr7: Bovine 20s Immunoproteasome
  386. 7drw: Bovine 20s Immunoproteasome in Complex with Two Human PA28ALPHA-BETA Activators
  387. 7ls5: Cryo-em Structure of The Pre3-1 20s Proteasome Core Particle
  388. 7ls6: Cryo-em Structure of Pre-15s Proteasome Core Particle Assembly Intermediate Purified from Pre3-1 Proteasome Mutant (G34D)
  389. 7lsx: Cryo-em Structure of 13s Proteasome Core Particle Assembly Intermediate Purified from Pre3-1 Proteasome Mutant (G34D)
  390. 6zou: Yeast 20s Proteasome in Complex with Glidobactin-like Natural Product Hb333
  391. 6zp6: Yeast 20s Proteasome in Complex with Glidobactin-like Natural Product Hb334
  392. 6zp8: Yeast 20s Proteasome in Complex with Glidobactin-like Natural Product Hb335
  393. 7awe: Human Immunoproteasome 20s Particle in Complex with [(1r)-2-(1- Benzofuran-3-yl)-1-{[(1s,2r,4r)-7-oxabicyclo[2.2.1]heptan-2- Yl]formamido}ethyl]boronic Acid
  394. 7nht: Akirin2 Bound Human Proteasome
  395. 7lxt: Structure of Plasmodium Falciparum 20s Proteasome with Bound Bortezomib
  396. 7lxu: Structure of Plasmodium Falciparum 20s Proteasome with Bound Mpi-5
  397. 7lxv: Structure of Human 20s Proteasome with Bound Mpi-5
  398. 7v5g: 20s+monoub-cyclinb1-nt (s1)
  399. 7v5m: 20s+monoub-cyclinb1-nt (s2)
  400. 7pg9: Human 20s Proteasome
  401. 7b12: Human Immunoproteasome 20s Particle in Complex with [2-(3- Ethylphenyl)-1-[(2s)-3-phenyl-2-[(pyrazin-2-yl) Formamido]propanamido]ethyl]boronic Acid
© Copyright 2008-2009 by enzymes.me.uk